Glycogen storage disease type II differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Glycogen storage disease type II}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Glycogen_storage_disease_type_II]]
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{Anmol}}
==Overview==
==Overview==
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
Infantile onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including [[hypotonia]], [[myopathy]], [[dyspnea]], feeding diffculties, absent reflex, [[macroglossia]], [[hepatomegaly]], [[heart failure]], elevated [[CK]], and [[cardiomegaly]]. Infantile onset glycogen storage disease should be differentiated from [[glycogen storage disease type 3]], [[Glycogen storage disease type IV|glycogen storage disease type 4]], acute Werdnig-Hoffman disease ([[spinal muscular atrophy]]), [[hypothyroidism]], [[endocardial fibroelastosis]], [[myocarditis]], [[congenital muscular dystrophy]], mitochondrial/respiratory chain disorder, peroxisomal disorders. Late onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including [[hypotonia]], [[muscle weakness]], respiratory imapirement, difficulty in walking, [[hepatomegaly]], elevated [[CK]], and [[cardiomyopathy]]. Late onset glycogen storage disease should be differentiated from [[glycogen storage disease type 3]], [[Glycogen storage disease type IV|glycogen storage disease type 4]], limb girdle muscle atrophy (LGMD), [[Becker's muscular dystrophy|Becker muscular dystrophy]] (BMD), scapuloperonral syndromes, [[Mitochondrial myopathy|mitochondrial myopathies]], [[myasthenia gravis]], [[spinal muscular atrophy]], [[polymyositis]].
 
OR
 
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].


==Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases==
==Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases==
*[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
*Infantile onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including [[hypotonia]], [[myopathy]], [[dyspnea]], feeding diffculties, absent reflex, [[macroglossia]], [[hepatomegaly]], [[heart failure]], elevated [[CK]], and [[cardiomegaly]]. Infantile onset glycogen storage disease should be differentiated from [[glycogen storage disease type 3]], [[Glycogen storage disease type IV|glycogen storage disease type 4]], acute Werdnig-Hoffman disease ([[spinal muscular atrophy]]), [[hypothyroidism]], [[endocardial fibroelastosis]], [[myocarditis]], [[congenital muscular dystrophy]], mitochondrial/respiratory chain disorder, peroxisomal disorders.
*[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
*Late onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including [[hypotonia]], [[muscle weakness]], respiratory imapirement, difficulty in walking, [[hepatomegaly]], elevated [[CK]], and [[cardiomyopathy]]. Late onset glycogen storage disease should be differentiated from [[glycogen storage disease type 3]], [[Glycogen storage disease type IV|glycogen storage disease type 4]], limb girdle muscle atrophy (LGMD), [[Becker's muscular dystrophy|Becker muscular dystrophy]] (BMD), scapuloperonral syndromes, [[Mitochondrial myopathy|mitochondrial myopathies]], [[myasthenia gravis]], [[spinal muscular atrophy]], [[polymyositis]].
 
*As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].


===Table Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases===
===Table Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases===
Line 35: Line 29:
!Cardiomegaly
!Cardiomegaly
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type II
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Glycogen storage disease type II'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 47: Line 41:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type III
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Glycogen storage disease type III]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 59: Line 53:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type IV
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Glycogen storage disease type IV]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 71: Line 65:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acute Werdnig-Hoffmann disease (spinal muscular atrophy)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Acute Werdnig-Hoffmann disease ([[spinal muscular atrophy]])'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 83: Line 77:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hypothyroidism]]'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
Line 95: Line 89:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endocardial fibroelastosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Endocardial fibroelastosis]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
Line 107: Line 101:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Myocarditis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Myocarditis]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
Line 119: Line 113:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital muscular dystrophy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Congenital muscular dystrophy]]'''
| style="background: #F5F5F5; padding: 5px;" | ++
| style="background: #F5F5F5; padding: 5px;" | ++
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 131: Line 125:
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mitochondrial/respiratory chain disorder
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mitochondrial/respiratory chain disorder'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
Line 143: Line 137:
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Peroxisomal disorders
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Peroxisomal disorders'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
Line 156: Line 150:
|}
|}


=== Table Differentiating Late Onset Glycogen Storage Disease Type II from other Diseases ===
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |Diseases
! colspan="4" |History and Symptoms
!Physical Examination
!Laboratory Findings
!Imaging findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Hypotonia
!Muscle weakness
!Respiratory impairement
!Difficulty in walking
!Hepatomegaly
!Elevated CK
!Cardiomyopathy
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Glycogen storage disease type II'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |Progressive [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Glycogen storage disease type III]]'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |Progressive [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Glycogen storage disease type IV]]'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |Progressive [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +/-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Limb girdle muscular atrophy (LMGD)'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Progressive [[muscle weakness]] in [[pelvis]], [[legs]], and [[shoulders]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Becker muscular dystrophy]] (BMD)'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Progressive proximal [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Scapuloperoneal syndromes'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Progressive [[muscle weakness]] behind the [[knee]] and around the [[shoulder]] blades
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Mitochondrial myopathy|Mitochondrial myopathies]]'''
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |[[Muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Myasthenia gravis]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Generalized [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Spinal muscular atrophy]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Asymmetrical [[muscle weakness]], atrophy of voluntary [[muscles]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Polymyositis]]'''
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Unexplained [[muscle weakness]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 161: Line 262:
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Pediatrics]]
[[Category:Up-To-Date]]
[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]


{{WS}}
{{WS}}
{{WH}}
{{WH}}

Latest revision as of 22:11, 8 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Infantile onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including hypotonia, myopathy, dyspnea, feeding diffculties, absent reflex, macroglossia, hepatomegaly, heart failure, elevated CK, and cardiomegaly. Infantile onset glycogen storage disease should be differentiated from glycogen storage disease type 3, glycogen storage disease type 4, acute Werdnig-Hoffman disease (spinal muscular atrophy), hypothyroidism, endocardial fibroelastosis, myocarditis, congenital muscular dystrophy, mitochondrial/respiratory chain disorder, peroxisomal disorders. Late onset glycogen storage disease type 2 (GSD type 2) must be differentiated from other diseases on the basis of characteristics including hypotonia, muscle weakness, respiratory imapirement, difficulty in walking, hepatomegaly, elevated CK, and cardiomyopathy. Late onset glycogen storage disease should be differentiated from glycogen storage disease type 3, glycogen storage disease type 4, limb girdle muscle atrophy (LGMD), Becker muscular dystrophy (BMD), scapuloperonral syndromes, mitochondrial myopathies, myasthenia gravis, spinal muscular atrophy, polymyositis.

Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases

Table Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases

Diseases History and Symptoms Physical Examination Laboratory Findings Imaging findings
Hypotonia Myopathy Dyspnea Feeding difficulties Absent reflex Macroglossia Hepatomegaly Heart failure Elevated CK Cardiomegaly
Glycogen storage disease type II + + + + + + + + + +
Glycogen storage disease type III - + - - - - + - + +
Glycogen storage disease type IV - + - - - - + - + +
Acute Werdnig-Hoffmann disease (spinal muscular atrophy) + + - - + - - - - -
Hypothyroidism + - - - - + - - - -
Endocardial fibroelastosis - - + + - - - + - +
Myocarditis - - - - - - - - - +
Congenital muscular dystrophy ++ + - - - - - - - -
Mitochondrial/respiratory chain disorder - + - - - - + - + +
Peroxisomal disorders + - - - - - + - - -

Table Differentiating Late Onset Glycogen Storage Disease Type II from other Diseases

Diseases History and Symptoms Physical Examination Laboratory Findings Imaging findings
Hypotonia Muscle weakness Respiratory impairement Difficulty in walking Hepatomegaly Elevated CK Cardiomyopathy
Glycogen storage disease type II + Progressive muscle weakness + + + + +
Glycogen storage disease type III + Progressive muscle weakness - - + + +/-
Glycogen storage disease type IV + Progressive muscle weakness - - + + +/-
Limb girdle muscular atrophy (LMGD) - Progressive muscle weakness in pelvis, legs, and shoulders - - - - -
Becker muscular dystrophy (BMD) - Progressive proximal muscle weakness + + - + -
Scapuloperoneal syndromes - Progressive muscle weakness behind the knee and around the shoulder blades - - + + +
Mitochondrial myopathies + Muscle weakness - - + + +
Myasthenia gravis - Generalized muscle weakness - - - - -
Spinal muscular atrophy - Asymmetrical muscle weakness, atrophy of voluntary muscles - - - - -
Polymyositis - Unexplained muscle weakness - - - - -

References

Template:WS Template:WH